Effect of SLC7A11 in dexmedetomidine pretreatment induced reduction of ferroptosis caused by intestinal ischemia-reperfusion injury in mice
10.12092/j.issn.1009-2501.2021.07.003
- Author:
Tianxue ZHANG
1
;
Lei ZHANG
1
;
Yingxiang HAO
1
;
Mingjing GAO
1
;
Lin WU
1
;
Yufang LENG
1
;
Yufang LENG
2
Author Information
1. The First School of Clinical Medicine, Lanzhou University
2. Department of Anesthesiology, The First Hospital of Lanzhou University
- Publication Type:Journal Article
- Keywords:
Dexmedetomidine;
Ferroptosis;
Intestines;
Reperfusion injury;
SLC7A11
- From:
Chinese Journal of Clinical Pharmacology and Therapeutics
2021;26(7):738-743
- CountryChina
- Language:Chinese
-
Abstract:
AIM: To evaluate the effect of SLC7A11 in dexmedetomidine pretreatment induced reduction of ferroptosis caused by intestinal ischemia-reperfusion (II/R) injury in mice. METHODS: Twenty-four healthy meal SPF C57BL/6J mice, aged 8 weeks, weighing 22-25 g, were randomly divided into Sham operation group (S group), intestinal I/R group (II/R group), dexmedetomidine group (DEX group) and dexmedetomidine plus SLC7A11 inhibitior group (DIKE group), with 6 mice in each group. Intestinal ischemia was induced by occluding the superior mesenteric artery for 45 min followed by 30 min of reperfusion to establish the model of II/R injury. In DEX and DIKE groups, Dexmedetomidine 25 μg/kg was intraperitoneally injected at 30 min before clamping the superior mesenteric artery. The same amount of normal saline was injected in the S group and the II/R group. In DIKE group, SLC7A11 inhibitior Imidazole ketone erastin 50 mg/kg was intraperitoneally injected at 90 min before ischemia. Mice were sacrificed 30 min after reperfusion, and small intestinal tissues in length 5 cm away from the ileocecal valvum were obtained for microscopic examination of pathological changes of intestinal mucosa and for determination of contents of Fe
